Abiopharma

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

McGrath Announces Completion of $725 Million Financing

Silvercrest Asset Management Group Inc. Reports Q1 2026 Results

Corpay与BVNK达成合作，为全球客户新增稳定币钱包服务

Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026

Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17

Corpay與BVNK達成合作，為全球客戶新增穩定幣錢包服務

Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026

Conduent Reports Significantly Improved First Quarter 2026 Financial Results